OQROGet OQRO Pro
Insider trade

Cytokinetics (CYTK)Director sold ~$306K

B Lynne Parshall, Director at Cytokinetics, sold ~$306K of Cytokinetics shares.

~$306K
Approx. value · 5,000 sh @ $61.21
18K
Holds after · shares reported
Traded
Mar 2, 2026
Filed
Mar 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 2, 2026Insider · 1 personInsiders: 2 sales (~$113K)
  2. Jan 5, 2026InsiderOfficer sold ~$904K of CYTK shares in the open market
  3. Feb 2, 2026InsiderOfficer sold ~$55K of CYTK shares in the open market
  4. Feb 5, 2026InsiderOfficer sold ~$929K of CYTK shares in the open market
  5. Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
  6. Mar 2, 2026 · this disclosureInsiderDirector sold ~$306K of CYTK shares in the open market

What came next

  1. Mar 2, 2026InsiderOfficer sold ~$55K of CYTK shares in the open market
  2. Mar 5, 2026Insider · 1 personInsiders: 2 sales (~$1.6M)
  3. Mar 9, 2026Insider · 3 peopleInsiders: 3 sales (~$815K)
  4. Mar 16, 2026InsiderOfficer sold ~$104K of CYTK shares in the open market
  5. Mar 17, 2026Insider · 4 peopleInsiders: 7 sales (~$3.9M)
  6. Mar 18, 2026InsiderOfficer sold ~$120K of CYTK shares in the open market
  7. Mar 31, 2026InsiderOfficer sold ~$237K of CYTK shares in the open market
  8. Apr 1, 2026InsiderCEO sold ~$500K of CYTK shares in the open market
  9. Apr 7, 2026Insider · 1 personInsiders: 2 sales (~$293K)
  10. Apr 15, 2026Insider · 2 peopleInsiders: 2 sales (~$982K)
  11. Apr 21, 2026InsiderOfficer sold ~$230K of CYTK shares in the open market
  12. Apr 29, 2026InsiderCEO sold ~$447K of CYTK shares in the open market
  13. Apr 30, 2026InsiderOfficer sold ~$949K of CYTK shares in the open market
  14. May 1, 2026InsiderOfficer sold ~$1.03M of CYTK shares in the open market
  15. May 5, 2026Company filing · Form 8-K · ResultsReported its results
  16. May 5, 2026Insider · 5 peopleInsiders: 5 sales (~$4.8M)
  17. May 14, 2026InsiderCEO sold ~$584K of CYTK shares in the open market
  18. May 19, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
  19. May 27, 2026InsiderCEO sold ~$579K of CYTK shares in the open market
  20. Jun 1, 2026Insider · 3 peopleInsiders: 3 sales (~$1.7M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by B Lynne Parshall, Director

The full history of B Lynne Parshall, Director is on the profile page.

How this filing works

Other disclosures at Cytokinetics

Everything OQRO holds on this company is on its CYTK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data